Current Value
$25.131 Year Return
Current Value
$25.131 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PRA | 0.01% | $767.34M | +22.85% | 0.00% |
PEG | -0.01% | $42.38B | +43.27% | 2.78% |
MTB | -0.02% | $32.36B | +48.43% | 2.74% |
AWR | 0.02% | $2.73B | -8.07% | 2.44% |
OCX | 0.02% | $36.20M | -35.82% | 0.00% |
CFR | 0.02% | $8.91B | +35.27% | 2.62% |
BHLB | -0.02% | $1.29B | +18.82% | 2.47% |
AR | 0.03% | $12.01B | +75.25% | 0.00% |
NECB | 0.03% | $337.48M | +44.59% | 1.99% |
ABT | 0.03% | $196.03B | -0.65% | 1.47% |
EHTH | -0.05% | $275.59M | +35.37% | 0.00% |
NPKI | -0.05% | $643.54M | +22.57% | 0.00% |
FUN | -0.06% | $4.64B | +17.74% | 1.25% |
BF.A | -0.06% | $16.21B | -39.59% | 2.54% |
PLG | -0.06% | $130.41M | +18.69% | 0.00% |
LVO | 0.06% | $112.89M | -7.81% | 0.00% |
MOS | 0.08% | $8.62B | -16.16% | 3.06% |
NEE | 0.08% | $139.79B | +12.64% | 2.97% |
INVH | 0.08% | $18.95B | -7.78% | 3.58% |
ABCB | -0.08% | $4.33B | +25.57% | 1.00% |
SeekingAlpha
Structure Therapeutics has a strong cash position with a runway of 18-20 quarters, but the drug's potential is not fully realized yet. Explore more details here.
SeekingAlpha
Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.
SeekingAlpha
Viking Therapeutics shows promise with weight loss drug VK2735 and potential in NASH treatment, making it a potential takeover target. Read more on VKTX here.
Yahoo
The low-risk approach by the drug giant is a sign of the extent of Eli Lilly and Novo Nordisk’s dominance in the weight-loss market.
Yahoo
Preclinical studies with ACCG-2671 demonstrate potent target engagement, robust weight loss, favorable safety profile and PK properties supportive of once-daily dosing in humans ACCG-2671 is the most advanced oral small molecule amylin-based drug candidate, with Phase 1 study initiation expected by year end 2025 Company to host conference call today at 4:30 p.m. Eastern Time SAN FRANCISCO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global bioph
Finnhub
Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity Preclinical studies with ACCG-2671...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HZO | 42.57% | $600.21M | -20.19% | 0.00% |
COHR | 42.35% | $14.38B | +105.93% | 0.00% |
DNLI | 30.95% | $2.70B | +2.01% | 0.00% |
AGIO | 30.55% | $1.90B | +51.87% | 0.00% |
CRNX | 29.48% | $3.30B | -4.50% | 0.00% |
NTLA | 29.09% | $991.50M | -63.62% | 0.00% |
CRSP | 28.42% | $3.27B | -39.52% | 0.00% |
ONEW | 28.31% | $221.96M | -48.96% | 0.00% |
OMER | 27.28% | $497.79M | +146.84% | 0.00% |
PRTA | 26.95% | $681.76M | -61.75% | 0.00% |
ARWR | 26.36% | $2.25B | -48.56% | 0.00% |
LAD | 26.10% | $9.47B | +23.61% | 0.59% |
IDYA | 25.92% | $1.97B | -43.88% | 0.00% |
CVAC | 25.14% | $883.77M | +6.78% | 0.00% |
GFL | 25.05% | $17.19B | +33.94% | 0.16% |
RARE | 25.05% | $3.70B | -9.05% | 0.00% |
RVMD | 25.02% | $7.26B | +45.47% | 0.00% |
SCVL | 24.71% | $822.85M | +17.87% | 1.72% |
VKTX | 24.62% | $3.78B | +59.60% | 0.00% |
KSS | 24.50% | $1.41B | -50.39% | 15.39% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SAIC | -22.98% | $5.70B | -8.36% | 1.25% |
PAC | -18.76% | $8.31B | +25.81% | 0.00% |
GSK | -18.24% | $65.45B | -19.56% | 4.76% |
WM | -18.13% | $83.15B | +14.60% | 1.44% |
TXO | -16.46% | $728.26M | -5.77% | 13.25% |
VRN | -16.20% | $3.34B | -15.68% | 6.05% |
CVE | -15.37% | $27.23B | -2.07% | 3.27% |
SU | -14.89% | $50.00B | +24.36% | 4.01% |
OVV | -14.77% | $11.71B | +11.06% | 2.65% |
MUR | -14.50% | $4.94B | -11.16% | 3.52% |
PNW | -14.33% | $9.46B | +19.15% | 4.20% |
ASR | -14.14% | $7.34B | +1.73% | 0.00% |
KR | -14.10% | $43.36B | +29.11% | 2.03% |
EOG | -14.01% | $76.36B | +21.07% | 2.67% |
MTDR | -13.20% | $7.83B | +17.12% | 1.34% |
BRY | -13.09% | $375.46M | -23.85% | 9.02% |
OXY | -13.05% | $48.87B | -8.02% | 1.69% |
XOM | -13.02% | $482.23B | +12.31% | 3.50% |
KNTK | -12.98% | $3.70B | +87.13% | 4.78% |
HAL | -12.80% | $24.77B | -15.85% | 2.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EWW | -17.03% | $1.10B | 0.5% |
FLMX | -15.35% | $70.88M | 0.19% |
TPMN | -12.71% | $41.70M | 0.65% |
XLE | -12.39% | $33.71B | 0.09% |
CTA | -12.05% | $536.34M | 0.76% |
VDE | -11.57% | $7.86B | 0.1% |
IYE | -11.40% | $1.33B | 0.39% |
FTXN | -11.16% | $166.21M | 0.6% |
DRLL | -11.02% | $318.59M | 0.41% |
RSPG | -10.94% | $549.42M | 0.4% |
DBE | -10.87% | $50.63M | 0.77% |
FENY | -10.71% | $1.55B | 0.084% |
BILZ | -10.69% | $616.87M | 0.14% |
IXC | -10.62% | $1.97B | 0.41% |
DBO | -10.30% | $228.06M | 0.77% |
UUP | -9.84% | $640.67M | 0.77% |
IEO | -9.69% | $605.94M | 0.4% |
PXE | -9.34% | $107.66M | 0.63% |
MLPA | -9.19% | $1.71B | 0.45% |
VRIG | -8.53% | $1.20B | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
LVHD | 0.01% | $508.43M | 0.27% |
DHS | 0.07% | $1.13B | 0.38% |
SPLV | 0.11% | $7.09B | 0.25% |
MSOS | -0.13% | $461.32M | 0.83% |
FXU | 0.15% | $325.66M | 0.64% |
FLTR | 0.16% | $1.97B | 0.14% |
SPHD | 0.22% | $3.28B | 0.3% |
XBIL | 0.28% | $642.09M | 0.15% |
FDL | -0.29% | $4.47B | 0.45% |
GII | -0.37% | $479.43M | 0.4% |
SOYB | -0.46% | $26.14M | 0.22% |
FUTY | 0.47% | $1.58B | 0.084% |
ARGT | 0.49% | $1.04B | 0.59% |
KIE | 0.52% | $881.72M | 0.35% |
TPHD | -0.67% | $237.71M | 0.52% |
XLU | -0.76% | $16.40B | 0.09% |
VPU | 0.81% | $6.42B | 0.1% |
RLY | 0.93% | $494.98M | 0.5% |
XLP | -0.93% | $15.91B | 0.09% |
EQLS | 0.95% | $8.93M | 1% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 33.69% | $6.18B | 0.35% |
PIN | 29.98% | $225.90M | 0.78% |
PTH | 28.01% | $117.64M | 0.6% |
ARKG | 26.58% | $1.09B | 0.75% |
IBB | 25.85% | $6.41B | 0.45% |
GNOM | 24.33% | $68.90M | 0.5% |
FBT | 24.03% | $1.17B | 0.56% |
XPH | 23.71% | $155.81M | 0.35% |
XRT | 23.36% | $407.30M | 0.35% |
PINK | 23.04% | $139.16M | 0.5% |
FALN | 22.07% | $1.92B | 0.25% |
ANGL | 21.92% | $3.01B | 0.25% |
EMXC | 21.62% | $15.05B | 0.25% |
XCEM | 21.30% | $1.10B | 0.16% |
PBE | 21.26% | $255.43M | 0.58% |
BBH | 21.05% | $398.49M | 0.35% |
ICLN | 21.00% | $1.39B | 0.41% |
IBUY | 20.75% | $178.30M | 0.65% |
AOM | 20.65% | $1.49B | 0.15% |
ISRA | 20.55% | $87.88M | 0.59% |